Larimar Therapeutics, Inc.
Nasdaq LRMR · Bala Cynwyd, PA
Works in Genetic & rare · Metabolic & endocrine · Neurology
Larimar Therapeutics, Inc. is a clinical trial sponsor based in Bala Cynwyd, PA, listed as Nasdaq LRMR. It has 2 active clinical trials with 235 planned participants, in Genetic & rare, Metabolic & endocrine and Neurology. Since 2021 it has completed 3 trials and stopped 1 early.
Trial track record · since 2021
Financials · Nasdaq LRMR
Fundraising
Pipeline · 2 active trials
| Stage | Trial | Status |
|---|---|---|
Questions about Larimar Therapeutics, Inc
Larimar Therapeutics, Inc is lead sponsor of 2 active clinical trials on ClinicalTrials.gov, with 235 planned participants, in Genetic & rare, Metabolic & endocrine, Neurology. Since 2021 it has completed 3 trials and stopped 1 early.
Larimar Therapeutics, Inc is based in Bala Cynwyd, PA and is listed as Nasdaq LRMR. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Larimar Therapeutics, Inc; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-09.
Approve Suite is not affiliated with Larimar Therapeutics, Inc.. Informational only.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.